# Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis

Groundbreaking research presented at the ECTRIMS 2025 conference held in Barcelona, Spain provides new insights into the ways in which menopause impacts the health implications and clinical manifestations in women who have multiple sclerosis. This study shows that changes in hormones influence the initial symptoms experienced by women with MS and also play a role in the comorbidities suffered by the affected individuals.

 For companies like Clene Inc. (NASDAQ: CLNN) focused on developing novel treatments for multiple sclerosis and other neurodegenerative diseases, the study could help in…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to Clene Inc. (NASDAQ: CLNN) are available in the company’s newsroom at https://ibn.fm/CLNN

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireSan Francisco, CAwww.BioMedWire.com415.949.5050 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/landmark-study-shows-how-menopause-influences-the-symptoms-of-multiple-sclerosis/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/menopause-found-to-significantly-impact-multiple-sclerosis-symptoms-in-women/7c5d976a484b63c957a73cea3c07cfe6) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202509/225679-new-research-reveals-menopause-s-significant-impact-on-multiple-sclerosis-symptoms-and-comorbidities)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202509/225708-estudio-revela-como-la-menopausia-influye-en-los-sintomas-de-la-esclerosis-multiple)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202509/225709-estudio-revela-como-la-menopausia-influye-en-los-sintomas-de-la-esclerosis-multiple)

Pickup - [https://faqstaq.news/news](https://faqstaq.news/news/202509/225457-faq-menopause-s-impact-on-multiple-sclerosis-symptoms-and-health-conditions)
 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/259/26/cornOx_B.webp)